Novartis Puts Down $50m For Mesoblast COVID-19 Cell Therapy

Reversal Of Fortunes For Remestemcel-L

 
• By Kevin Grogan
  
Rescue
Novartis comes to Mesoblast's rescue • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from COVID-19

More from Scrip